Association factors of target organ damage: Analysis of 17 682 elderly hypertensive patients in China

Chinese Medical Journal

Volumn 124, Issue 22, 2011, Pages 3676-3681

  Cui, Hua ^a   Wang, Fan ^b   Fan, Li ^c   Hu, Yi Xin ^a   Hu, Guo Liang ^b   Liu, Lin ^b   Hong, Chang Ming ^a  

^a Nanlou Cardiology Department 2   (China)

^b Nanlou Healthcare Department   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Elderly inpatients; Hypertension; Risk factors; Target organ damage

Indexed keywords

HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; AORTA DISSECTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; CEREBROVASCULAR DISEASE; CHINA; CHINESE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; ESSENTIAL HYPERTENSION; FEMALE; GERIATRIC PATIENT; GLOMERULUS FILTRATION RATE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; ORGAN INJURY; PREVALENCE; PULSE PRESSURE; RETROSPECTIVE STUDY; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TARGEN ORGAN DAMAGE;

AGED; AGED, 80 AND OVER; AORTIC DISEASES; CEREBROVASCULAR DISORDERS; CHINA; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; FEMALE; GLOMERULAR FILTRATION RATE; HOMOCYSTEINE; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 82255195506     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.22.014     Document Type: Article

References (28)

1. Waeber B, de la Sierra A, Ruilope LM. Target organ damage: how to detect it and how to treat it? J Hypertens Suppl 2009; 27: S13-S8.
2. Papadopoulos DP, Makris TK, Papademetriou V. Is it time to treat prehypertension? Hypertens Res 2008; 31: 1681-1686.
3. Mensah GA, Croft JB, Giles WH. The heart, kidney, and brain as target organs in hypertension. Cardiol Clin 2002; 20: 225-247.
4. Zhang XF, Attia J, D'Este K, Yu XH, Wu XG. Prevalence and magnitude of classical risk factors for coronary heart disease in a cohort of 4400 Chinese steelworkers over 13.5 years follow-up. Eur J Cardiovasc Prev Rehabil 2004; 11: 113-120.
5. Onwuanyi A, Hodges D, Avancha A, Weiss L, Rabinowitz D, Shea S, et al. Hypertensive vascular disease as a cause of death in blacks versus whites: autopsy findings in 587 adults. Hypertension 1998; 31: 1070-1076.
6. Peer N, Steyn K, Dennison CR, Levitt NS, Nyo MT, Nel JH, et al. Determinants of target organ damage in black hypertensive patients attending primary health care services in Cape Town: the Hi-Hi study. Am J Hypertens 2008; 21: 896-902.
7. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, IzzoJr JL, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: The JNC 7 Report. JAMA 2003; 289: 2560-2571.
8. Whitworth JA, World Health Organization International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21: 1983-1992.
9. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ 2004; 328: 634-640.
10. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation 2003; 108: 1772-1778.
11. Al-Shahi Salman R, Berg MJ, Morrison L, Awad IA. Hemorrhage from cavernous malformations of the brain: definition and reporting standards. Angioma Alliance Scientific Advisory Board. Stroke 2008; 39: 3222-3230.
12. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease evaluation, classification and stratification. Am J Kidney Dis 2002; 39 (2 Suppl 1): S1-S266.
13. Wang F, Ye P, Luo L, Xiao W, Wu H. Association of risk factors for cardiovascular disease and glomerular filtration rate: a community-based study of 4925 adults in Beijing. Nephrol Dial Transplant 2010; 25: 3924-3931.
14. Holden RM, Morton AR, Garland JS, Pavlov A, Day AG, Booth SL. Vitamins K and D status in stages 3-5 chronic kidney disease. Clin J Am Soc Nephrol 2010; 5: 590-597.
15. Giugliano G, Spadera L, De Laurentis M, Brevetti G. Chronic aortic dissection: still a challenge. Acta Cardiol 2009; 64: 653-663.
16. Hu J, Wallace DC, Jones E, Liu H. Cardiometabolic health of Chinese older adults with diabetes living in Beijing, China. Public Health Nurs 2009; 26: 500-511.
17. White WB. Systolic versus diastolic blood pressure versus pulse pressure. Curr Cardiol Rep 2002; 4: 463-467.
18. The Association Committee of Prevention and Treatment of Dyslipidemia. The 2007 Guidelines for Prevention and Treatment of Dyslipidemia in Adults in China. Chin J Cardiol (Chin) 2007; 35: 390-413.
19. Nakagami T, Tajima N, Oizumi T, Karasawa S, Wada K, Kameda W, et al. Raised fasting plasma glucose a better predictor of diabetes than the IDF definition of the metabolic syndrome. Diabetes Res Clin Pract 2009; 85: e19-e21.
20. Turhan H, Erbay AR, Yasar AS, Bicer A, Sahin O, Basar N, et al. Plasma homocysteine levels in patients with isolated coronary artery ectasia. Int J Cardiol 2005; 104: 158-162.
21. Lin JD, Chiou WK, Chang HY, Liu FH, Weng HF. Serum uric acid and leptin levels in metabolic syndrome: a quandary over the role of uric acid. Metabolism 2007; 56: 751-756.
22. Addo J, Smeeth L, Leon DA. Prevalence, detection, management, and control of hypertension in Ghanaian civil servants. Ethn Dis 2008; 18: 505-511.
23. Linjer E, Jörnmark J, Hedner T, Jönsson B. Stop Hypertension-2 Group. Predictors for high costs of hospital care in elderly hypertensive patients. Blood Press 2006; 15: 245-250.
24. Liebson PR. Cardiovascular disease in special populations III: stroke. Prev Cardiol 2010; 13: 1-7.
25. Navarro J, Redón J, Cea-Calvo L, Lozano JV, Fernández-Pérez C, Bonet A, et al. Metabolic syndrome, organ damage and cardiovascular disease in treated hypertensive patients. The ERIC-HTA study. Blood Press 2007; 16: 20-27.
26. Cuspidi C, Meani S, Salerno M, Fusi V, Severgnini B, Valerio C, et al. Retinal microvascular changes and target organ damage in untreated essential hypertensives. J Hypertens 2004; 22: 2095-2102.
27. Barrios V, Escobar C, Calderón A, Echarri R, González-Pedel V, Ruilope LM. CONTROLRISK Investigators. Cardiovascular risk profile and risk stratification of the hypertensive population attended by general practitioners and specialists in Spain. The CONTROLRISK study. J Hum Hypertens 2007; 21: 479-485.
28. Cuspidi C, Valerio C, Sala C, Esposito A, Masaidi M, Negri F, et al. Prevalence and correlates of multiple organ damage in a never-treated hypertensive population: role of ambulatory blood pressure. Blood Press Monit 2008; 13: 7-13.